Get the Stockscreener App
184.99
0.48%
0.89
Pre-market:
185.00
0.010
+0.01%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $184.99, with a volume of 1.99M.
It is up +0.48% in the last 24 hours and down -32.31% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$184.10
Open:
$184.28
24h Volume:
1.99M
Relative Volume:
1.05
Market Cap:
$22.25B
Revenue:
$126.36B
Net Income/Loss:
$1.30B
P/E Ratio:
17.34
EPS:
10.6697
Net Cash Flow:
$1.55B
1W Performance:
+2.04%
1M Performance:
-32.31%
6M Performance:
-35.41%
1Y Performance:
-27.12%
1-Day Range:
$183.00
$187.65
1-Week Range:
$169.61
$187.65
52-Week Range:
$169.61
$315.35
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
184.99 | 22.14B | 126.36B | 1.30B | 1.55B | 10.67 |
|
UNH
Unitedhealth Group Inc
|
289.09 | 265.58B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
78.20 | 99.84B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
290.71 | 76.78B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
344.78 | 76.54B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana commits $1.7 million for Illinois health programs - StreetInsider
Humana Invests $1.7 Million to Drive Better Health Outcomes Across Illinois - Business Wire
Analyst recommendations: Costco, Amex, Draftkings, Humana, Vertiv… - marketscreener.com
Truist Financial Reaffirms Their Hold Rating on Humana (HUM) - The Globe and Mail
Humana’s CenterWell buys primary care provider MaxHealth - Healthcare Dive
Humana (HUM): Goldman Sachs Maintains "Sell" Rating, Cuts Price Target | HUM Stock News - GuruFocus
Humana's CenterWell acquires MaxHealth primary care clinics - TechTarget
Humana's CenterWell closes deal to buy primary care provider MaxHealth from Arsenal Capital Partners - Fierce Healthcare
Humana (NYSE:HUM) Price Target Lowered to $200.00 at Truist Financial - MarketBeat
Truist Securities Adjusts Humana Price Target to $200 From $285, Maintains Hold Rating - marketscreener.com
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers - GlobeNewswire Inc.
CenterWell (Humana) Completes Acquisition Of Florida Primary Care Platform MaxHealth - Pulse 2.0
Humana’s 2026 Guidance and the Crisis in Managed Care - The Chronicle-Journal
Medicare Advantage growth dwindles for a second straight year - statnews.com
Will Humana Inc outperform its industry peers2025 Price Targets & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Humana could end 2026 as the largest Medicare Advantage insurer - InsuranceNewsNet
Humana Inc. $HUM Shares Sold by Tobam - MarketBeat
Humana Inc. $HUM Holdings Lifted by Aberdeen Group plc - MarketBeat
Arsenal sells primary care provider MaxHealth to Humana’s CenterWell - pehub.com
Humana (HUM) Is Down 5.1% After Cautious 2026 EPS Outlook And Medicare Advantage Headwinds – What’s Changed - simplywall.st
Envestnet Asset Management Inc. Has $19.47 Million Stock Position in Humana Inc. $HUM - MarketBeat
Humana Bolsters CenterWell Primary Care With Another Deal - Forbes
Humana (HUM) Valuation Reset After Earnings Miss And 2026 Medicare Advantage Profit Warning - simplywall.st
Humana (HUM) Expands with MaxHealth Acquisition - GuruFocus
Humana (NYSE:HUM) Price Target Lowered to $158.00 at The Goldman Sachs Group - MarketBeat
Humana buys primary care organization, MaxHealth (HUM:NYSE) - Seeking Alpha
Humana Reports Wider Quarterly Loss, Expects 2026 Earnings Decline - The Wall Street Journal
ProShare Advisors LLC Cuts Position in Humana Inc. $HUM - MarketBeat
Caprock Group LLC Takes $2.09 Million Position in Humana Inc. $HUM - MarketBeat
TD Cowen Maintains Hold Rating on Humana (HUM) Amid Price Target Cut | HUM Stock News - GuruFocus
Deal Dispatch: Britney Spears Sells, Humana Eyes MaxHealth, Mercedes Spins Off Stake - Bitget
Humana acquires MaxHealth, adds dozens of clinics to CenterWell - Modern Healthcare
Humana’s Star-Crossed Guidance: Why a Q4 Beat Couldn't Save the Stock from a 2026 Tailspin - The Chronicle-Journal
Humana Buys Clinic Operator MaxHealth From Arsenal Capital - Bloomberg.com
CenterWell Completes Acquisition of MaxHealth From Arsenal Capital Partners - Business Wire
Humana Shares Plunge as $3.5 Billion Star Ratings Headwind Forces Conservative 2026 Guidance - The Chronicle-Journal
Goldman Sachs Adjusts Price Target on Humana to $158 From $215, Maintains Sell Rating - marketscreener.com
Humana is said to be near $1B deal for MaxHealth - Modern Healthcare
Humana (NYSE:HUM) Price Target Cut to $180.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Humana Bets On Google Cloud AI To Tackle Costs And Service - simplywall.st
Humana stock rating downgraded by RBC Capital on Medicare Advantage risk - Investing.com Australia
Renderings for proposed Humana Tower renovations highlighted at mayor's State of the City address - WDRB
Humana (HUM) stock rebounds after earnings shock — Star Ratings and Medicare rates now drive the price - Bez Kabli
Balanced Risk-Reward Amid Growth Ambitions and Margin Rebuild Supports Humana Hold Rating - TipRanks
Humana Is Said to Near $1 Billion Deal for Florida’s MaxHealth - Bloomberg.com
Renderings for Humana Tower renovations highlighted at Greenberg's State of the City Address - WDRB
Humana sells Hikes Lane medical office building for $2.5 million - WDRB
Humana sells medical office building on Hikes Lane - WDRB
PHOTOS: First look at new hotel set to replace former Humana tower in downtown Louisville - WHAS11
Jefferies Maintains Buy Rating on Humana (HUM) but Lowers Price Target | HUM Stock News - GuruFocus
Humana (HUM): UBS Lowers Price Target, Maintains Neutral Rating - GuruFocus
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.60%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):